The median (IQR) serum level of galectin-3 in patients with a moderate-to-high severity was lower than in those patients with a minor stroke (l8.2[6.2-13.8]ng/ml vs. 5.8[3.6-7.9]ng/m; P<0.001), Figure 2. This evidence concerns the gene LGALS3 and stroke disorder.